Abstract:Transforming growth factor-β (TGF-β) is the primary factor that drives fibrosis in most, if not all, forms of chronic kidney disease (CKD). However, direct targeting of TGF-β is unlikely to be therapeutically feasible due to the involvement of TGF-β in other systems, including the immune system. Hence, the aim of this study was to identify Sirtuin 2 (SIRT2) as an endogenous regulatory of TGF-β signaling and renal fibrosis. In current study, we demonstrated that SIRT2 was downregulated in the renal tubules of patients with CKD and DKD, as well as a mouse model of renal fibrosis. In kidneys that are obstructed, specific deletion of Sirt2 in renal tubule epithelial cells (TEC) were shown to substantially aggravate renal fibrosis, and renal tubule specific overexpression of Sirt2 was sufficient to ameliorate renal fibrosis. Additionally, we showed that SIRT2 overexpression and knockdown restrained and enhanced TGF-β-induced fibrotic gene expression, respectively, in TEC. Mechanistically, SIRT2 reduced the phosphorylation, nuclear localization, and protein levels of SMAD2, leading to inhibition of the TGF-β signaling pathway. Further studies found that SIRT2 was able to directly interact with and deacetylate SMAD2 on lysine 451 and promote its ubiquitination and degradation. The mutation of lysine 451 to arginine in SMAD2 blocks the regulatory effect of SIRT2. Notably, loss of SMAD specific E3 ubiquitin protein ligase 2 abolished the ubiquitination and degradation of SMAD2 induced by SIRT2 in SMAD2. This study provides initial indication of the anti-fibrotic role of SIRT2 in renal tubules, suggesting its therapeutic potential for renal fibrosis.Funding Information: This work was supported by grants from the National Natural Science Foundation of China (82000824 to SY, 82170842 to ZL, 82171556 to LK), the Natural Science Foundation of Shenzhen City, China to ZL (No. KCXFZ20201221173600001), the National Key Research and Development Program of China (2018YFC2001100). Declaration of Interests: The authors have declared that no conflict of interest exists.Ethics Approval Statement: This study was approved by the Institutional Review Board and Ethics Committee of the Shenzhen People’s Hospital (approval no. LL-KT-2018338). Written informed consent was obtained from all participants prior to their inclusion in the study.All Animal care and experimental protocols for in vivo studies conformed to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH; NIH publication no.:85–23, revised 1996) and were approved by the Ethics Committee of the Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital (Shenzhen, China).

The Spermine Oxidase/Spermine Axis Coordinates ATG5‐Mediated Autophagy to Orchestrate Renal Senescence and Fibrosis

Atg5 Deficiency in Macrophages Protects Against Kidney Fibrosis Via the CCR6-CCL20 Axis

MiR-155-5p Promotes Renal Interstitial Fibrosis in Obstructive Nephropathy Via Inhibiting SIRT1 Signaling Pathway

Spermine Ameliorates Ischemia/reperfusion Injury in Cardiomyocytes Via Regulation of Autophagy.

Mitophagy Induced by UMI-77 Preserves Mitochondrial Fitness in Renal Tubular Epithelial Cells and Alleviates Renal Fibrosis

Spermidine from arginine metabolism activates Nrf2 and inhibits kidney fibrosis

Spermidine attenuates bleomycin-induced lung fibrosis by inducing autophagy and inhibiting endoplasmic reticulum stress (ERS)-induced cell death in mice

Inhibition of Polyamine Catabolism Reduces Cellular Senescence

Spermidine coupled with exercise rescues skeletal muscle atrophy from D-gal-induced aging rats through enhanced autophagy and reduced apoptosis via AMPK-FOXO3a signal pathway

Resveratrol ameliorates muscle atrophy in chronic kidney disease via the axis of SIRT1/FoxO1

AMPK activation coupling SENP1-Sirt3 axis protects against acute kidney injury

SMN Haploinsufficiency Promotes Ischemia/ Reperfusion-Induced AKI-to-CKD Transition by Endoplasmic Reticulum Stress Activation.

Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway

Nuclear Translocation of SIRT4 Mediates Deacetylation of U2AF2 to Modulate Renal Fibrosis Through Alternative Splicing-mediated Upregulation of CCN2

SIRT2 Alleviated Renal Fibrosis by Deacetylating Conserved Lysine 451 on SMAD2 in Renal Tubular Epithelial Cells

Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis

Inhibition of HSP90 S‐nitrosylation alleviates cardiac fibrosis via TGFβ/SMAD3 signalling pathway

Spermidine-Activated Satellite Cells Are Associated with Hypoacetylation in ACVR2B and Smad3 Binding to Myogenic Genes in Mice

Sirtuin 5 Alleviates Excessive Mitochondrial Fission Via Desuccinylation Of Atpase Inhibitory Factor 1 In Sepsis-Induced Acute Kidney Injury

TGFβ-incurred Epigenetic Aberrations of Mirna and DNA Methyltransferase Suppress Klotho and Potentiate Renal Fibrosis

Spermine oxidase is up-regulated and promotes tumor growth in hepatocellular carcinoma.